These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3105879)

  • 21. Neuroendocrine derangement in chronic migraine.
    Patacchioli FR; Martelletti P
    Headache; 2006 Sep; 46(8):1309-10. PubMed ID: 16942481
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
    Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
    Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides.
    Zoumakis E; Margioris AN; Makrigiannakis A; Stournaras C; Gravanis A
    J Endocrinol Invest; 1997 Mar; 20(3):158-67. PubMed ID: 9186824
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical aspects of suicide.
    Asberg M
    Clin Neuropharmacol; 1986; 9 Suppl 4():374-6. PubMed ID: 3032431
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice.
    Anisman H; Prakash P; Merali Z; Poulter MO
    Behav Brain Res; 2007 Aug; 181(2):180-90. PubMed ID: 17517441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders.
    Keck ME; Ohl F; Holsboer F; Müller MB
    Neurosci Biobehav Rev; 2005; 29(4-5):867-89. PubMed ID: 15899517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine regulation of thyroid-stimulating hormone secretion in amphibians.
    Okada R; Kobayashi T; Yamamoto K; Nakakura T; Tanaka S; Vaudry H; Kikuyama S
    Ann N Y Acad Sci; 2009 Apr; 1163():262-70. PubMed ID: 19456347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of exercise on adrenocortical responsiveness of patients with chronic low back pain, controlled for psychological strain.
    Chatzitheodorou D; Mavromoustakos S; Milioti S
    Clin Rehabil; 2008 Apr; 22(4):319-28. PubMed ID: 18390975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.
    Merali Z; Khan S; Michaud DS; Shippy SA; Anisman H
    Eur J Neurosci; 2004 Jul; 20(1):229-39. PubMed ID: 15245495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of hypophysiotrophic corticotrophin-releasing hormone- and thyrotrophin-releasing hormone-synthesising neurones by brainstem catecholaminergic neurones.
    Wittmann G
    J Neuroendocrinol; 2008 Jul; 20(7):952-60. PubMed ID: 18445123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR; Nemeroff CB
    J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRH-sub-1 receptor antagonists for the treatment of depression and anxiety.
    Ising M; Holsboer F
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):519-28. PubMed ID: 18179304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring the neurobiological and psychopathological course in therapy of depression. Trimipramine, sleep deprivation and light].
    Holsboer-Trachsler E
    Bibl Psychiatr; 1994; (166):1-138. PubMed ID: 7980382
    [No Abstract]   [Full Text] [Related]  

  • 37. The combined dexamethasone/CRH test as a potential surrogate marker in depression.
    Ising M; Künzel HE; Binder EB; Nickel T; Modell S; Holsboer F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1085-93. PubMed ID: 15950349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal stress: opposite effects on anxiety and hypothalamic expression of vasopressin and corticotropin-releasing hormone in rats selectively bred for high and low anxiety.
    Bosch OJ; Krömer SA; Neumann ID
    Eur J Neurosci; 2006 Jan; 23(2):541-51. PubMed ID: 16420461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can stress cause depression?
    van Praag HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):891-907. PubMed ID: 15363612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.